AI in clinical trials

Oncology

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

R&D

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Digital

Read Medidata’s 2nd annual survey, 'The State of AI in Clinical Trials. From Pilot to Practice: Insights into AI Adoption, Impact, and Expectations'.

Digital

With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.

R&D

The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.

Digital

AI can help sponsors identify higher-potential sites, improve enrolment predictability, and accelerate study startup timelines.